The legacy of Viagra and the pharmaceutical industry presents a challenging picture for potential investors. Initially, copyright's blockbuster drug altered the treatment of erectile dysfunction, creating substantial profits and defining the contemporary pharmaceutical landscape. However, intellectual property expiration and the appearance of gener